Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT07262645RecruitingPhase 3
Light therapy for mild Alzheimer's disease
This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.
Beijing, Beijing MunicipalityAges 50–85 - NCT07262476RecruitingPhase 3
Extension study of MHB018A for thyroid eye disease
This study tests a longer-term use of MHB018A for people with thyroid eye disease who did not fully respond to treatment in a previous study. It aims to see if further treatment can help improve eye bulging and other symptoms.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07265258RecruitingPhase 4
Teprotumumab for active thyroid eye disease
This study tests a drug called teprotumumab for people with active thyroid eye disease. It is designed to help reduce eye bulging and other symptoms, and may be an option if you have not had strong treatments before.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05761275Recruiting
Sexual quality of life after minimally invasive benign surgery
This study looks at how minimally invasive “vNOTES” surgery affects women’s sexual quality of life after a non-cancer (benign) gynecologic procedure. You might be eligible if you recently had this type of surgery and meet specific health, infection, and language requirements.
GenevaAges 18–70 - NCT07261345RecruitingEarly Phase 1
CAR-T cell therapy for hard-to-treat Graves' disease
This early-phase trial tests whether specially engineered immune cells (called CAR-T) can treat Graves' disease that hasn't responded to standard medication. It's for people with active, hard-to-control Graves' who have the TRAb antibody.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07267403Recruiting
Brain activity and sedation during anesthesia
This trial studies how stimulating a nerve in the wrist affects brain activity and sedation levels during propofol anesthesia. It may help improve care for right-handed patients having surgery.
BrusselsAges 18–81 - NCT07259512RecruitingPhase 4
Ramipril once or twice a day for kidney and heart health
This trial tests whether taking ramipril once or twice daily better protects kidney function in people with both chronic kidney disease (stages 3-5, not on dialysis) and heart failure with low pumping strength. It aims to find the best dosing schedule to help both organs.
Kartasura, Central JavaAges 18 years+ - NCT07265544Recruiting
Liver disease study using advanced tissue analysis
This study uses advanced techniques to analyze liver tissue samples from people with various liver conditions. It aims to better understand how liver diseases develop and progress, which may help improve future treatments.
Guangzhou, GuangdongAges Any age - NCT07263880RecruitingPhase 1/Phase 2
Clostridium Butyricum for stricturing Crohn's disease
This trial tests a bacteria called Clostridium butyricum to see if it can help people with a type of Crohn's disease that causes narrowing in the right colon or ileocecal area. It may offer a new option for those not on strong immune-suppressing medications.
RomaAges 18–85 - NCT07260071Recruiting
High blood pressure in kids at risk for inherited kidney disease
This study looks for early signs of high blood pressure in children and teens (12–17) who have a parent with ADPKD, a kidney condition. It uses non-invasive tests like blood pressure monitoring and MRI to track kidney health.
LondonAges 12–17 - NCT07264439Recruiting
Virtual reality with hypnosis for Alzheimer's patients during hygiene care
This trial tests whether virtual reality headsets showing hypnosis scenes can reduce agitation and resistance during bathing or toileting in people with Alzheimer's disease. It aims to make daily care calmer and less stressful for patients and caregivers.
AmiensAges 18 years+ - NCT07268599Enrolling by invitation
Acoltremon for moderate-to-severe dry eye relief
This study tests a new eye drop called Acoltremon to see if it can relieve symptoms of moderate-to-severe dry eye disease. It may be a good option if you have had dry eye for at least 6 months and use artificial tears.
Encino, CaliforniaAges 18–60 - NCT06068361Recruiting
Better diagnosis of Lewy body dementia
This study uses a combination of tests to improve diagnosis of dementia with Lewy bodies compared to Alzheimer's disease and healthy aging. You may help doctors identify the right diagnosis more accurately.
Paris, FranceAges 55–85 - NCT04856501Recruiting
Parenting support for preterm toddlers’ brain and self-control
This study tests whether a responsive parenting program helps toddlers born early think, learn, and manage behavior more easily. It also checks whether families can complete toddler brain and behavior assessments (including brain scans).
Houston, TexasAges 1.3 years–2.5 years - NCT05435222Recruiting
Male-only therapy program for major depression
This study tests a counseling/psychotherapy program designed specifically for men with major depression. If you qualify, you may be offered this structured therapy and followed to see whether it helps depressive symptoms.
Zurich, Canton of ZurichAges 25–50 - NCT06715007Recruiting
Study on blood thinners and artery health for small vessel stroke
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
Nanjing, JiangsuAges 30–79 - NCT04442789Recruiting
Study of lasting effects after COVID-19 hospitalization
This study looks at what health problems remain after a person was hospitalized for COVID-19. It may help doctors understand these long-lasting effects and how to care for people afterward.
GiessenAges 18 years+ - NCT04046796Recruiting
Study genetics in identical twin who differ in symptoms
This study looks at DNA changes to explain why two identical (monozygotic) twins can have different symptoms. It may help clarify the cause of an unclear condition in one twin so the right diagnosis (and future treatment) can be found.
TübingenAges Any age - NCT05848271Recruiting
Natural history study for people with HPDL gene changes
This study follows people who have an HPDL gene change to better understand how symptoms and health progress over time. It may help clinicians learn more about the condition and plan future treatments.
San Diego, CaliforniaAges Any age - NCT07258303Recruiting
Probiotic Spray for Gum Disease in Older Adults
This trial tests an oral spray that contains good bacteria (probiotics) to help prevent and treat gum disease in older adults. It may be a simple addition to your daily routine to support gum health.
Hanoi, HanoiAges 35 years+ - NCT07252440RecruitingPhase 2
Testing an oral drug for early Alzheimer's disease
This study tests an oral tablet (TTYP01) for people with early Alzheimer's disease. It aims to see if the drug can slow memory loss. You must have a study partner who can support you throughout the trial.
Chongqing, Chongqing MunicipalityAges 55–85 - NCT06902415Recruiting
Using a computer analysis platform for brain blood vessel disease
This study uses a special computer platform to analyze DSA scan images from people with brain blood vessel diseases. It aims to better understand their condition and guide treatment decisions.
Beijing, Beijing MunicipalityAges 1–80 - NCT07253038Recruiting
Testing social skills in Huntington's disease
This study tests three different ways to measure social skills (like understanding emotions or reading social cues) in people with Huntington's disease. The goal is to find which test works best for future research and care.
LundAges 18–75
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,577 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.